Mounjaro (Tirzepatide) Acts on two hormones (GLP-1 + GIP), hence more potent in reducing blood sugar and aiding weight loss
A study done in 2022 by the Institute for Clinical and Economic Review found that the cost associated with cardiovascular risks does not decrease with the inclusion of GLP-1s in a drug formulary when used for weight loss (as initially thought)
Phase II neutralizes them by covalently attaching a conjugation group (glucuronic acid, glutathione, sulfate, acetyl, methyl, or amino acid) that increases polarity, reduces reactivity, and enables transport into bile or urine
Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinsons disease model
If you have started a new exercise plan with weights, you might be building strong, healthy muscle